FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S. CNBCFDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease CNNLilly Wins FDA Approval for New Drug to Slow Alzheimer’s Disease BNN BloombergFDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s The New York Times